Public Citizen Petition to FDA to Warn Against Prolonged Use of Clopidogrel (Plavix) in Cardiac-Stent Patients Because of Lethal
Public Citizen petitions the Food and Drug Administration to warn patients and doctors that taking the widely prescribed drug clopidogrel (brand name: Plavix) for more than a year after having a drug-eluting stent implanted can lead to potentially fatal bleeding without providing further benefits.
September 12, 2013, Initial response from FDA
February 18, 2014, Interim response from FDA
December 21, 2018, final response from the FDA